You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 94 23 486 or email: subscribe@krixos.com |
|
Most viewed
- 1. American Cancer Society reports latest global cancer statistics; Cancer cases approach 21 million worldwide, with burden projected to surge 67% by 2050
- 2. Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
- 3. Genome editing in rats enables more accurate ER+ breast cancer models
- 4. Researchers discover new form of hereditary prostate cancer
- 5. Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight
- 6. ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
- 7. Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight
- 8. Impact of Patients' Preoperative Psychological Baseline on Postoperative Voice and Quality of Life Following Pharyngo-Laryngectomy with Anterolateral Thigh Flap Reconstruction: A Preliminary Study
- 9. Breast cancer is rising fast in Asian American women
- 10. Combination treatment harnesses cellular recycling system to fight multiple myeloma
Last updated at 19:26 GMT
